2018-2023 Global Cancer Vaccines Drug Pipeline Market Report (Status and Outlook)

October 2018 | 116 pages | ID: 2DB9FA37460EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Cancer Vaccines Drug Pipeline market for 2018-2023.

Cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity.
Germany, the U.S. and Japan represent the largest markets for cancer vaccine manufacturers.
Over the next five years, LPI(LP Information) projects that Cancer Vaccines Drug Pipeline will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Cancer Vaccines Drug Pipeline market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• Therapeutic Vaccine
• Prophylactic Vaccine

Segmentation by application:

• Ambulatory Care Centers
• Hospital

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Eisai
• F. Hoffmann-La Roche
• Arbor Pharmaceuticals
• Bristol-Myers Squibb
• Merck

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Cancer Vaccines Drug Pipeline market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Cancer Vaccines Drug Pipeline market by identifying its various subsegments.
• Focuses on the key global Cancer Vaccines Drug Pipeline players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Cancer Vaccines Drug Pipeline with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Cancer Vaccines Drug Pipeline submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Cancer Vaccines Drug Pipeline Market Size 2013-2023
  2.1.2 Cancer Vaccines Drug Pipeline Market Size CAGR by Region
2.2 Cancer Vaccines Drug Pipeline Segment by Type
  2.2.1 Therapeutic Vaccine
  2.2.2 Prophylactic Vaccine
2.3 Cancer Vaccines Drug Pipeline Market Size by Type
  2.3.1 Global Cancer Vaccines Drug Pipeline Market Size Market Share by Type (2013-2018)
  2.3.2 Global Cancer Vaccines Drug Pipeline Market Size Growth Rate by Type (2013-2018)
2.4 Cancer Vaccines Drug Pipeline Segment by Application
  2.4.1 Ambulatory Care Centers
  2.4.2 Hospital
2.5 Cancer Vaccines Drug Pipeline Market Size by Application
  2.5.1 Global Cancer Vaccines Drug Pipeline Market Size Market Share by Application (2013-2018)
  2.5.2 Global Cancer Vaccines Drug Pipeline Market Size Growth Rate by Application (2013-2018)

3 GLOBAL CANCER VACCINES DRUG PIPELINE BY PLAYERS

3.1 Global Cancer Vaccines Drug Pipeline Market Size Market Share by Players
  3.1.1 Global Cancer Vaccines Drug Pipeline Market Size by Players (2016-2018)
  3.1.2 Global Cancer Vaccines Drug Pipeline Market Size Market Share by Players (2016-2018)
3.2 Global Cancer Vaccines Drug Pipeline Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CANCER VACCINES DRUG PIPELINE BY REGIONS

4.1 Cancer Vaccines Drug Pipeline Market Size by Regions
4.2 Americas Cancer Vaccines Drug Pipeline Market Size Growth
4.3 APAC Cancer Vaccines Drug Pipeline Market Size Growth
4.4 Europe Cancer Vaccines Drug Pipeline Market Size Growth
4.5 Middle East & Africa Cancer Vaccines Drug Pipeline Market Size Growth

5 AMERICAS

5.1 Americas Cancer Vaccines Drug Pipeline Market Size by Countries
5.2 Americas Cancer Vaccines Drug Pipeline Market Size by Type
5.3 Americas Cancer Vaccines Drug Pipeline Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Cancer Vaccines Drug Pipeline Market Size by Countries
6.2 APAC Cancer Vaccines Drug Pipeline Market Size by Type
6.3 APAC Cancer Vaccines Drug Pipeline Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Cancer Vaccines Drug Pipeline by Countries
7.2 Europe Cancer Vaccines Drug Pipeline Market Size by Type
7.3 Europe Cancer Vaccines Drug Pipeline Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Cancer Vaccines Drug Pipeline by Countries
8.2 Middle East & Africa Cancer Vaccines Drug Pipeline Market Size by Type
8.3 Middle East & Africa Cancer Vaccines Drug Pipeline Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL CANCER VACCINES DRUG PIPELINE MARKET FORECAST

10.1 Global Cancer Vaccines Drug Pipeline Market Size Forecast (2018-2023)
10.2 Global Cancer Vaccines Drug Pipeline Forecast by Regions
  10.2.1 Global Cancer Vaccines Drug Pipeline Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Cancer Vaccines Drug Pipeline Forecast by Type
10.8 Global Cancer Vaccines Drug Pipeline Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Eisai
  11.1.1 Company Details
  11.1.2 Cancer Vaccines Drug Pipeline Product Offered
  11.1.3 Eisai Cancer Vaccines Drug Pipeline Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Eisai News
11.2 F. Hoffmann-La Roche
  11.2.1 Company Details
  11.2.2 Cancer Vaccines Drug Pipeline Product Offered
  11.2.3 F. Hoffmann-La Roche Cancer Vaccines Drug Pipeline Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 F. Hoffmann-La Roche News
11.3 Arbor Pharmaceuticals
  11.3.1 Company Details
  11.3.2 Cancer Vaccines Drug Pipeline Product Offered
  11.3.3 Arbor Pharmaceuticals Cancer Vaccines Drug Pipeline Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Arbor Pharmaceuticals News
11.4 Bristol-Myers Squibb
  11.4.1 Company Details
  11.4.2 Cancer Vaccines Drug Pipeline Product Offered
  11.4.3 Bristol-Myers Squibb Cancer Vaccines Drug Pipeline Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Bristol-Myers Squibb News
11.5 Merck
  11.5.1 Company Details
  11.5.2 Cancer Vaccines Drug Pipeline Product Offered
  11.5.3 Merck Cancer Vaccines Drug Pipeline Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Merck News

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Cancer Vaccines Drug Pipeline
Figure Cancer Vaccines Drug Pipeline Report Years Considered
Figure Market Research Methodology
Figure Global Cancer Vaccines Drug Pipeline Market Size Growth Rate 2013-2023 ($ Millions)
Table Cancer Vaccines Drug Pipeline Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of Therapeutic Vaccine
Table Major Players of Prophylactic Vaccine
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Cancer Vaccines Drug Pipeline Market Size Market Share by Type (2013-2018)
Figure Global Cancer Vaccines Drug Pipeline Market Size Market Share by Type (2013-2018)
Figure Global Therapeutic Vaccine Market Size Growth Rate
Figure Global Prophylactic Vaccine Market Size Growth Rate
Figure Cancer Vaccines Drug Pipeline Consumed in Ambulatory Care Centers
Figure Global Cancer Vaccines Drug Pipeline Market: Ambulatory Care Centers (2013-2018) ($ Millions)
Figure Global Ambulatory Care Centers YoY Growth ($ Millions)
Figure Cancer Vaccines Drug Pipeline Consumed in Hospital
Figure Global Cancer Vaccines Drug Pipeline Market: Hospital (2013-2018) ($ Millions)
Figure Global Hospital YoY Growth ($ Millions)
Table Global Cancer Vaccines Drug Pipeline Market Size by Application (2013-2018) ($ Millions)
Table Global Cancer Vaccines Drug Pipeline Market Size Market Share by Application (2013-2018)
Figure Global Cancer Vaccines Drug Pipeline Market Size Market Share by Application (2013-2018)
Figure Global Cancer Vaccines Drug Pipeline Market Size in Ambulatory Care Centers Growth Rate
Figure Global Cancer Vaccines Drug Pipeline Market Size in Hospital Growth Rate
Table Global Cancer Vaccines Drug Pipeline Revenue by Players (2016-2018) ($ Millions)
Table Global Cancer Vaccines Drug Pipeline Revenue Market Share by Players (2016-2018)
Figure Global Cancer Vaccines Drug Pipeline Revenue Market Share by Players in 2017
Table Global Cancer Vaccines Drug Pipeline Key Players Head office and Products Offered
Table Cancer Vaccines Drug Pipeline Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Cancer Vaccines Drug Pipeline Market Size by Regions 2013-2018 ($ Millions)
Table Global Cancer Vaccines Drug Pipeline Market Size Market Share by Regions 2013-2018
Figure Global Cancer Vaccines Drug Pipeline Market Size Market Share by Regions 2013-2018
Figure Americas Cancer Vaccines Drug Pipeline Market Size 2013-2018 ($ Millions)
Figure APAC Cancer Vaccines Drug Pipeline Market Size 2013-2018 ($ Millions)
Figure Europe Cancer Vaccines Drug Pipeline Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Cancer Vaccines Drug Pipeline Market Size 2013-2018 ($ Millions)
Table Americas Cancer Vaccines Drug Pipeline Market Size by Countries (2013-2018) ($ Millions)
Table Americas Cancer Vaccines Drug Pipeline Market Size Market Share by Countries (2013-2018)
Figure Americas Cancer Vaccines Drug Pipeline Market Size Market Share by Countries in 2017
Table Americas Cancer Vaccines Drug Pipeline Market Size by Type (2013-2018) ($ Millions)
Table Americas Cancer Vaccines Drug Pipeline Market Size Market Share by Type (2013-2018)
Figure Americas Cancer Vaccines Drug Pipeline Market Size Market Share by Type in 2017
Table Americas Cancer Vaccines Drug Pipeline Market Size by Application (2013-2018) ($ Millions)
Table Americas Cancer Vaccines Drug Pipeline Market Size Market Share by Application (2013-2018)
Figure Americas Cancer Vaccines Drug Pipeline Market Size Market Share by Application in 2017
Figure United States Cancer Vaccines Drug Pipeline Market Size Growth 2013-2018 ($ Millions)
Figure Canada Cancer Vaccines Drug Pipeline Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Cancer Vaccines Drug Pipeline Market Size Growth 2013-2018 ($ Millions)
Table APAC Cancer Vaccines Drug Pipeline Market Size by Countries (2013-2018) ($ Millions)
Table APAC Cancer Vaccines Drug Pipeline Market Size Market Share by Countries (2013-2018)
Figure APAC Cancer Vaccines Drug Pipeline Market Size Market Share by Countries in 2017
Table APAC Cancer Vaccines Drug Pipeline Market Size by Type (2013-2018) ($ Millions)
Table APAC Cancer Vaccines Drug Pipeline Market Size Market Share by Type (2013-2018)
Figure APAC Cancer Vaccines Drug Pipeline Market Size Market Share by Type in 2017
Table APAC Cancer Vaccines Drug Pipeline Market Size by Application (2013-2018) ($ Millions)
Table APAC Cancer Vaccines Drug Pipeline Market Size Market Share by Application (2013-2018)
Figure APAC Cancer Vaccines Drug Pipeline Market Size Market Share by Application in 2017
Figure China Cancer Vaccines Drug Pipeline Market Size Growth 2013-2018 ($ Millions)
Figure Japan Cancer Vaccines Drug Pipeline Market Size Growth 2013-2018 ($ Millions)
Figure Korea Cancer Vaccines Drug Pipeline Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Cancer Vaccines Drug Pipeline Market Size Growth 2013-2018 ($ Millions)
Figure India Cancer Vaccines Drug Pipeline Market Size Growth 2013-2018 ($ Millions)
Figure Australia Cancer Vaccines Drug Pipeline Market Size Growth 2013-2018 ($ Millions)
Table Europe Cancer Vaccines Drug Pipeline Market Size by Countries (2013-2018) ($ Millions)
Table Europe Cancer Vaccines Drug Pipeline Market Size Market Share by Countries (2013-2018)
Figure Europe Cancer Vaccines Drug Pipeline Market Size Market Share by Countries in 2017
Table Europe Cancer Vaccines Drug Pipeline Market Size by Type (2013-2018) ($ Millions)
Table Europe Cancer Vaccines Drug Pipeline Market Size Market Share by Type (2013-2018)
Figure Europe Cancer Vaccines Drug Pipeline Market Size Market Share by Type in 2017
Table Europe Cancer Vaccines Drug Pipeline Market Size by Application (2013-2018) ($ Millions)
Table Europe Cancer Vaccines Drug Pipeline Market Size Market Share by Application (2013-2018)
Figure Europe Cancer Vaccines Drug Pipeline Market Size Market Share by Application in 2017
Figure Germany Cancer Vaccines Drug Pipeline Market Size Growth 2013-2018 ($ Millions)
Figure France Cancer Vaccines Drug Pipeline Market Size Growth 2013-2018 ($ Millions)
Figure UK Cancer Vaccines Drug Pipeline Market Size Growth 2013-2018 ($ Millions)
Figure Italy Cancer Vaccines Drug Pipeline Market Size Growth 2013-2018 ($ Millions)
Figure Russia Cancer Vaccines Drug Pipeline Market Size Growth 2013-2018 ($ Millions)
Figure Spain Cancer Vaccines Drug Pipeline Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Cancer Vaccines Drug Pipeline Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Cancer Vaccines Drug Pipeline Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Cancer Vaccines Drug Pipeline Market Size Market Share by Countries in 2017
Table Middle East & Africa Cancer Vaccines Drug Pipeline Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Cancer Vaccines Drug Pipeline Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Cancer Vaccines Drug Pipeline Market Size Market Share by Type in 2017
Table Middle East & Africa Cancer Vaccines Drug Pipeline Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Cancer Vaccines Drug Pipeline Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Cancer Vaccines Drug Pipeline Market Size Market Share by Application in 2017
Figure Egypt Cancer Vaccines Drug Pipeline Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Cancer Vaccines Drug Pipeline Market Size Growth 2013-2018 ($ Millions)
Figure Israel Cancer Vaccines Drug Pipeline Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Cancer Vaccines Drug Pipeline Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Cancer Vaccines Drug Pipeline Market Size Growth 2013-2018 ($ Millions)
Figure Global Cancer Vaccines Drug Pipeline arket Size Forecast (2018-2023) ($ Millions)
Table Global Cancer Vaccines Drug Pipeline Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Cancer Vaccines Drug Pipeline Market Size Market Share Forecast by Regions
Figure Americas Cancer Vaccines Drug Pipeline Market Size 2018-2023 ($ Millions)
Figure APAC Cancer Vaccines Drug Pipeline Market Size 2018-2023 ($ Millions)
Figure Europe Cancer Vaccines Drug Pipeline Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Cancer Vaccines Drug Pipeline Market Size 2018-2023 ($ Millions)
Figure United States Cancer Vaccines Drug Pipeline Market Size 2018-2023 ($ Millions)
Figure Canada Cancer Vaccines Drug Pipeline Market Size 2018-2023 ($ Millions)
Figure Mexico Cancer Vaccines Drug Pipeline Market Size 2018-2023 ($ Millions)
Figure Brazil Cancer Vaccines Drug Pipeline Market Size 2018-2023 ($ Millions)
Figure China Cancer Vaccines Drug Pipeline Market Size 2018-2023 ($ Millions)
Figure Japan Cancer Vaccines Drug Pipeline Market Size 2018-2023 ($ Millions)
Figure Korea Cancer Vaccines Drug Pipeline Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Cancer Vaccines Drug Pipeline Market Size 2018-2023 ($ Millions)
Figure India Cancer Vaccines Drug Pipeline Market Size 2018-2023 ($ Millions)
Figure Australia Cancer Vaccines Drug Pipeline Market Size 2018-2023 ($ Millions)
Figure Germany Cancer Vaccines Drug Pipeline Market Size 2018-2023 ($ Millions)
Figure France Cancer Vaccines Drug Pipeline Market Size 2018-2023 ($ Millions)
Figure UK Cancer Vaccines Drug Pipeline Market Size 2018-2023 ($ Millions)
Figure Italy Cancer Vaccines Drug Pipeline Market Size 2018-2023 ($ Millions)
Figure Russia Cancer Vaccines Drug Pipeline Market Size 2018-2023 ($ Millions)
Figure Spain Cancer Vaccines Drug Pipeline Market Size 2018-2023 ($ Millions)
Figure Egypt Cancer Vaccines Drug Pipeline Market Size 2018-2023 ($ Millions)
Figure South Africa Cancer Vaccines Drug Pipeline Market Size 2018-2023 ($ Millions)
Figure Israel Cancer Vaccines Drug Pipeline Market Size 2018-2023 ($ Millions)
Figure Turkey Cancer Vaccines Drug Pipeline Market Size 2018-2023 ($ Millions)
Figure GCC Countries Cancer Vaccines Drug Pipeline Market Size 2018-2023 ($ Millions)
Table Global Cancer Vaccines Drug Pipeline Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Cancer Vaccines Drug Pipeline Market Size Market Share Forecast by Type (2018-2023)
Table Global Cancer Vaccines Drug Pipeline Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Cancer Vaccines Drug Pipeline Market Size Market Share Forecast by Application (2018-2023)
Table Eisai Basic Information, Head Office, Major Market Areas and Its Competitors
Table Eisai Cancer Vaccines Drug Pipeline Revenue and Gross Margin (2016-2018)
Figure Eisai Cancer Vaccines Drug Pipeline Market Share (2016-2018)
Table F. Hoffmann-La Roche Basic Information, Head Office, Major Market Areas and Its Competitors
Table F. Hoffmann-La Roche Cancer Vaccines Drug Pipeline Revenue and Gross Margin (2016-2018)
Figure F. Hoffmann-La Roche Cancer Vaccines Drug Pipeline Market Share (2016-2018)
Table Arbor Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Arbor Pharmaceuticals Cancer Vaccines Drug Pipeline Revenue and Gross Margin (2016-2018)
Figure Arbor Pharmaceuticals Cancer Vaccines Drug Pipeline Market Share (2016-2018)
Table Bristol-Myers Squibb Basic Information, Head Office, Major Market Areas and Its Competitors
Table Bristol-Myers Squibb Cancer Vaccines Drug Pipeline Revenue and Gross Margin (2016-2018)
Figure Bristol-Myers Squibb Cancer Vaccines Drug Pipeline Market Share (2016-2018)
Table Merck Basic Information, Head Office, Major Market Areas and Its Competitors
Table Merck Cancer Vaccines Drug Pipeline Revenue and Gross Margin (2016-2018)
Figure Merck Cancer Vaccines Drug Pipeline Market Share (2016-2018)